ChemotherapyFDA-approvedFirst-line
Fludarabine
How it works
Interferes with DNA synthesis, causing cancer cells to die.
Cancer types
Leukemia— All patients
Efficacy
In clinical trials, around 40% of patients achieved a complete response, with a median overall survival of approximately 2 years.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Reduced Intensity Conditioning for Adults with Acute Lymphoblastic Leukemia | Leukemia | phase-2 | — | Source → |
| Testing Imetelstat with Fludarabine and Cytarabine for Leukemia and Blood Disorders | Leukemia | phase-1 | — | Source → |
| Combining Vitamin D and Fludarabine May Help Treat Leukemia | Leukemia | lab-study | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.